Security key
005083100
ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (ACTU)
CUSIP: 005083100
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, par value $0.000001 per share
- Total 13F shares
- 10,401,592
- Total 13F value
- $70,445,498
- Share change
- +285,456
- SEC-reported price per share
- $6.77
- Number of holders
- 25
- Value change
- +$1,934,199
- Number of buys
- 19
- Number of sells
- 4
- Shares outstanding
- 23,561,857
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
25
Top holders
10
ACTU full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Previous quarter: Q4 2024
ACTUATE THERAPEUTICS, INC. SEC filings
ACTUATE THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 005083100
Recent filing periods:
Ownership snapshot
Top reported holders of ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BIOS Capital Management, LP
Disclosed value leader
BIOS Capital Management, LP
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
Lead comparable stake: 42%
Showing 1-6 of 15 holder rows.
Quick read
BIOS Capital Management, LP leads the comparable SEC ownership view at 42%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BIOS Capital Management, LP's linked filing trail.
Comparable ownership
Top 5
BIOS Capital Management, LP
42%
Voss Capital, LP
0.23%
GEODE CAPITAL MANAGEMENT, LLC
0.12%
NORTHWESTERN UNIVERSITY
0.12%
MERCER GLOBAL ADVISORS INC /ADV
0.07%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BIOS Capital Management, LP |
13F
Company
|
42%
|
$78,753,462
9,893,651 shares
|
— | 31 Dec 2024 |
| Voss Capital, LP |
13F
Company
|
0.23%
|
$439,758
55,246 shares
|
— | 31 Dec 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.12%
|
$222,028
27,893 shares
|
— | 31 Dec 2024 |
| NORTHWESTERN UNIVERSITY |
13F
Company
|
0.12%
|
$221,111
27,778 shares
|
— | 31 Dec 2024 |
| MERCER GLOBAL ADVISORS INC /ADV |
13F
Company
|
0.07%
|
$130,098
16,344 shares
|
— | 31 Dec 2024 |
| Sigma Planning Corp |
13F
Company
|
0.07%
|
$127,957
16,075 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
25
Shares
10,401,592
Rows available
25
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
19
Q1 2025 holders
25
Holder diff
6
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend